Literature DB >> 23739990

In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.

Patrick B Memvanga1, Pierre Eloy, Eric M Gaigneaux, Véronique Préat.   

Abstract

PURPOSE: We aimed to assess the fate of β-arteether lipid-based drug delivery systems (AE-LBDDS) in terms of resistance to lipolysis and permeation across intestinal cells.
METHODS: AE-LBDDS contained Tween 80 or Cremophor EL as surfactants, ethanol, Maisine 35-1 and vegetable oil. The solubilization behavior of AE was investigated during dynamic in vitro lipolysis. The permeation of AE-LBDDS was evaluated using Caco-2, HT29-MTX and M cell monolayers.
RESULTS: A higher level of AE precipitation was observed for formulations containing Cremophor EL (~30%) compared to formulations containing Tween 80 (~10%) after lipolysis. However, rapid re-dissolution of the precipitated AE from LBDDS containing Cremophor EL in the intestinal biorelevant media was observed. The transport of AE loaded in LBDDS was enhanced in comparison to that of free drug due to the increased AE solubility. The apparent permeability of all AE-LBDDS across Caco-2 cell monolayers was approximately 3.10(-6) cm/s. A decrease in the permeability was observed at 4°C. M cells did not influence the transport of AE-LBDDS, and mucus decreased AE permeability when formulated with Tween 80. Furthermore, AE is not a P-glycoprotein substrate.
CONCLUSION: LBDDS that are partly resistant to in vitro lipolysis significantly increased the transport of AE across intestinal cell monolayers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739990     DOI: 10.1007/s11095-013-1094-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  43 in total

Review 1.  Nano-emulsions and micro-emulsions: clarifications of the critical differences.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2010-11-06       Impact factor: 4.200

2.  Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium.

Authors:  Anne des Rieux; Eva G E Ragnarsson; Elisabet Gullberg; Véronique Préat; Yves-Jacques Schneider; Per Artursson
Journal:  Eur J Pharm Sci       Date:  2005 Jul-Aug       Impact factor: 4.384

3.  Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.

Authors:  C M O'Driscoll; B T Griffin
Journal:  Adv Drug Deliv Rev       Date:  2007-11-06       Impact factor: 15.470

4.  Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.

Authors:  Kazi Mohsin; Michelle A Long; Colin W Pouton
Journal:  J Pharm Sci       Date:  2009-10       Impact factor: 3.534

5.  Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells.

Authors:  P Augustijns; A D'Hulst; J Van Daele; R Kinget
Journal:  J Pharm Sci       Date:  1996-06       Impact factor: 3.534

6.  Development of an in vitro digestion method to assess carotenoid bioavailability from meals.

Authors:  D A Garrett; M L Failla; R J Sarama
Journal:  J Agric Food Chem       Date:  1999-10       Impact factor: 5.279

7.  Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats.

Authors:  Arik Dahan; Amnon Hoffman
Journal:  Pharm Res       Date:  2006-08-11       Impact factor: 4.200

8.  Fatty acid uptake by Caco-2 human intestinal cells.

Authors:  P J Trotter; S Y Ho; J Storch
Journal:  J Lipid Res       Date:  1996-02       Impact factor: 5.922

Review 9.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.

Authors:  Christopher J H Porter; Natalie L Trevaskis; William N Charman
Journal:  Nat Rev Drug Discov       Date:  2007-03       Impact factor: 84.694

Review 10.  In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems.

Authors:  Anne T Larsen; Philip Sassene; Anette Müllertz
Journal:  Int J Pharm       Date:  2011-03-15       Impact factor: 5.875

View more
  3 in total

1.  Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation.

Authors:  Zhiwen Zhang; Shijun Jiang; Zeying Liu; Baohua Niu; Wangwen Gu; Yaping Li; Jingbin Cui
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

2.  Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor.

Authors:  Young-Guk Na; Jin-Ju Byeon; Miao Wang; Hyun Wook Huh; Gi-Ho Son; Sung-Hoon Jeon; Ki-Hyun Bang; Sung-Jin Kim; Hye-Jin Lee; Hong-Ki Lee; Cheong-Weon Cho
Journal:  Int J Nanomedicine       Date:  2019-02-15

3.  The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations.

Authors:  Tengfei Weng; Jianping Qi; Yi Lu; Kai Wang; Zhiqiang Tian; Kaili Hu; Zongning Yin; Wei Wu
Journal:  J Nanobiotechnology       Date:  2014-09-24       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.